Related Experiment Video
Updated: May 29, 2026
08:29
Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
Genomic instability in cultured stem cells: associated risks and underlying mechanisms
Andrew L Ross1, Daniel E Leder, Jonathan Weiss
1Interdisciplinary Stem Cell Institute, University of Miami, Miller School of Medicine, Miami, FL 33136, USA. grichnik@miami.edu
Regenerative Medicine
|September 16, 2011
Summary
Cultured stem cells like embryonic stem cells show genomic instability, increasing cancer risk. Understanding chromosomal defects is vital for safe stem cell therapies.
Area of Science:
- Stem cell biology
- Genetics
- Cancer research
Background:
- Embryonic stem cells (ESCs), mesenchymal stem cells (MSCs), and induced pluripotent stem cells (iPSCs) are crucial for regenerative medicine.
- In vitro expansion of these cells is associated with genomic instability, raising safety concerns.
Purpose of the Study:
- To review the genomic abnormalities observed in cultured stem cells.
- To explore the mechanisms underlying genomic instability in these cells.
- To highlight the implications for stem cell transplantation safety.
Main Methods:
- Literature review of studies reporting genomic abnormalities in cultured stem cells.
- Analysis of proposed mechanisms contributing to genomic instability.
- Discussion of the impact of genomic instability on clinical applications.
Main Results:
- Common abnormalities include aneuploidy, deletions, and duplications, mirroring cancer-associated alterations.
- Genomic instability increases the risk of malignant transformation.
- Potential mechanisms involve DNA repair defects, telomere issues, and mitotic errors.
Conclusions:
- Genomic instability in cultured stem cells poses a significant risk for transplantation safety.
- Further research into the mechanisms of chromosomal defect accrual is essential.
- Developing strategies to prevent genomic instability is critical for the advancement of regenerative medicine.
Related Concept Videos
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...